Clinical Trends for February 2017

Ryan Syrek


February 24, 2017

Clinical Trend of the Week (January 28 – February 3): Prostate Cancer

Insights into imaging studies, a drop in treatment, and a new marker for aggressive therapy resulted in this week's top search term. British researchers concluded that multiparametric MRI (MP-MRI) used as a triage test before an initial transrectal ultrasound biopsy could identify at least a quarter of men who could safely avoid biopsy and may improve detection of clinically significant prostate cancer. Meanwhile, a new marker was identified that helps indicate which men with prostate cancer would benefit from more aggressive therapy. Finally, a new study published in the January edition of Health Affairs found that treatment rates for prostate cancer have declined significantly from 2007 to 2012. This was in response to recommendations by the US Preventive Services Task Force to avoid overdiagnosis and overtreatment. This combination of significant news clustered around one condition no doubt resulted in this week's top search.

For more information on prostate cancer, read here.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.